Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus; T2DM
Interventions: Drug: HM15275; Drug: Placebo of HM15275
Sponsors: Hanmi Pharmaceutical Company Limited
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 15, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments